KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Income from Continuing Operations (2016 - 2025)

Evolent Health (EVH) has 11 years of Income from Continuing Operations data on record, last reported at 429208000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 1780.59% year-over-year to 429208000.0; the TTM value through Dec 2025 reached 534536000.0, down 767.13%, while the annual FY2025 figure was 534536000.0, 767.25% down from the prior year.
  • Income from Continuing Operations reached 429208000.0 in Q4 2025 per EVH's latest filing, down from 20858000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 3053000.0 in Q4 2021 and bottomed at 429208000.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 37907100.0, with a median of 18583500.0 recorded in 2024.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 139.66% in 2021, then tumbled 1780.59% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 3053000.0 in 2021, then tumbled by 471.54% to 11343000.0 in 2022, then tumbled by 194.55% to 33411000.0 in 2023, then surged by 31.69% to 22823000.0 in 2024, then crashed by 1780.59% to 429208000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 429208000.0 in Q4 2025, 20858000.0 in Q3 2025, and 19852000.0 in Q2 2025.